Floatz logo

Therapeutic Asset Ratings

132 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Metformin
Metastatic Solid Tumor
Turning Point Therapeutics, Inc.P1C (37)
Moma-313
Metastatic Solid Tumor
MOMA TherapeuticsP1C (37)
Moma-341
Metastatic Solid Tumor
MOMA TherapeuticsP1C (37)
Msk-Tcr5
Metastatic Solid Tumor
Memorial Sloan Kettering Cancer CenterP1C (37)
Niraparib
Metastatic Solid Tumor
University of California, San FranciscoP1C (37)
Nvl-330
Metastatic Solid Tumor
Nuvalent Inc.P1C (37)
Pemigatinib
Metastatic Solid Tumor
Massachusetts General HospitalP1C (37)
pep07
Metastatic Solid Tumor
PharmaEngineP1C (37)
Plx-61639
Metastatic Solid Tumor
Plexium, Inc.P1C (37)
prt7732
Metastatic Solid Tumor
Prelude TherapeuticsP1C (37)
Pyrotinib
Metastatic Solid Tumor
BeiGeneP1C (37)
rc48-adc
Metastatic Solid Tumor
BeiGeneP1C (37)
Rosuvastatin
Metastatic Solid Tumor
Turning Point Therapeutics, Inc.P1C (37)
sot201
Metastatic Solid Tumor
SOTIO Biotech AGP1C (37)
Sotorasib
Metastatic Solid Tumor
Navire Pharma Inc., a BridgeBio companyP1C (37)
syn608
Metastatic Solid Tumor
Hangzhou SynRx Therapeutics Biomedical Technology Co., LtdP1C (37)
syn818
Metastatic Solid Tumor
Hangzhou SynRx Therapeutics Biomedical Technology Co., LtdP1C (37)
Tach101
Metastatic Solid Tumor
Tachyon Therapeutics, Inc.P1C (37)
Tolododekin Alfa
Metastatic Solid Tumor
Ankyra Therapeutics, IncP1C (37)
Toripalimab
Metastatic Solid Tumor
Coherus Oncology, Inc.P1C (37)
ty-2136b
Metastatic Solid Tumor
TYK Medicines, IncP1C (37)
Wm-A1-3389
Metastatic Solid Tumor
Wellmarker BioP1C (37)
Wtx-124
Metastatic Solid Tumor
Werewolf Therapeutics, Inc.P1C (37)
xb628
Metastatic Solid Tumor
ExelixisP1C (37)
Xirestomig
Metastatic Solid Tumor
Antengene (Hangzhou) Biologics Co., Ltd.P1C (37)
Showing 101 to 125 of 132 assets
PreviousPage 5 of 6Next